Term Name: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
Synonyms: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+)acceptor) inhibitors, EC 1.1.1.* inhibitor, EC 1.1.1.* inhibitors, oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor (EC 1.1.1.*) inhibitor, oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor (EC 1.1.1.*) inhibitors
Definition: An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).
Ontology: ChEBI [CHEBI:76835]  ( EBI )

Relationships
is a type of: EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor
has subtype: EC 1.1.1.1 (alcohol dehydrogenase) inhibitor EC 1.1.1.21 (aldehyde reductase) inhibitor EC 1.1.1.25 (shikimate dehydrogenase) inhibitor EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor EC 1.1.1.37 (malate dehydrogenase) inhibitor EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor EC 1.1.1.188 (prostaglandin-F synthase) inhibitor EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor EC 1.1.1.205 (IMP dehydrogenase) inhibitor EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor